Anaphylaxis to Pegylated Liposomal Doxorubicin: A Case Report

Journal Authors: 

LR Sharma

A Subedi

BK Shah

Issue: 

Vol 63, Issue 4: Aug (2014)

DOI: 

10.7727/wimj.2013.270

Pages: 

376–7

ABSTRACT 

 

Liposomal doxorubicin is used for the treatment of various cancers like epithelial ovarian cancers, multiple myeloma and sarcomas. We report the first case of anaphylaxis to pegylated liposomal doxorubicin.

 

Received: 

08 Oct, 2013

Accepted: 

30 Oct, 2013

Keywords: 

Anaphylaxis

doxorubicin

liposomes

PDF Attachment: 

sharma_et_al_anaphylaxis_to_pegylated_liposomal_doxorubicin.pdf

e-Published: 19 May, 2014